Showing results (11-20 of 295) with videos related to
Sort By:
Pageof 30
Archives of Pathology & Laboratory Medicine|September 3, 2013
Genotype and phenotype concordance for pharmacogenetic tests through proficiency survey testingAlan H B WuCurrent Heart Failure Reports|September 17, 2013
Biological and analytical variation of clinical biomarker testing: implications for biomarker-guided therapyAlan H B WuLaboratory Medicine|November 18, 2020
The Impact of Mass Spectrometry on Patients' Medical and Nonmedical LivesAlan H B WuPharmacogenomics|February 5, 2008
Use of genetic and nongenetic factors in warfarin dosing algorithmsAlan H B WuAmerican Heart Journal|October 31, 2006
Serial testing of B-type natriuretic peptide and NTpro-BNP for monitoring therapy of heart failure: the role of biologic variation in the interpretation of resultsAlan H B WuClinics in Laboratory Medicine|February 11, 2014
Biomarkers for cholesterol absorption and synthesis in hyperlipidemic patients: role for therapeutic selectionAlan H B WuEJIFCC|September 30, 2016
Biomarkers Beyond the Natriuretic Peptides for Chronic Heart Failure: Galectin-3 and Soluble ST2Alan H B WuThe Journal of Applied Laboratory Medicine|October 23, 2019
XW-100: First FDA CLIA-Waived CBC Analyzer Designed for Physician Office UseAlan H B Wu, Jill SellersClinica Chimica Acta; International Journal of Clinical Chemistry|October 23, 2012
Implementation of liquid chromatography/mass spectrometry into the clinical laboratoryAlan H B Wu, Deborah FrenchLaboratory Medicine|June 13, 2024
Early detection of myocardial infarction with reference to baseline levels during health: impact on biological variation of high-sensitivity cardiac troponinAlan H B Wu, Sally GragliaPageof 30